Sitemap
November 18, 2024 Articles
Filter by Available Specialty
- 9 stories for Antibiotic Awareness Week
- Addressing economic insecurities ‘could improve’ patient reported outcomes in lupus
- Aldeyra receives PDUFA date for reproxalap, expands AbbVie option agreement
- Cardiovascular factors, including hypertension, associated with risk for severe stroke
- CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
- Cigarette to e-cigarette switch improves wheeze, dual use does not
- Community engagement can help stock inhaler programs succeed in rural schools
- Concern about potential telehealth surge in low-value care unsupported by real-world data
- Dry eye questionnaire may not be effective diagnostic tool for children
- Email ‘nudges’ highlighting flu vaccine’s heart benefits improve uptake
- Exposure to DDT, other pesticides exhibits ‘strong’ risk for rheumatoid arthritis
- FDA approves revumenib for certain patients with advanced acute leukemia
- First investigational oral therapy lowers Lp(a) in phase 2 study
- First US case of clade I mpox reported in California
- Focus on drug adherence, follow-up reduces racial disparities in juvenile arthritis
- Food access in formerly redlined neighborhoods tied to poor cardiometabolic health
- GLP-1RAs may offer ‘hepatoprotective’ benefit for diabetes, alcohol-related liver disease
- Health-seeking behaviors improve allergic rhinitis
- Heart failure drug may be ‘cardioprotective strategy’ for high-risk patients with cancer
- IL-6, JAK inhibitors, rituximab increase severe infection risk in inflammatory arthritis
- Immune checkpoint inhibitor therapy doubles psoriasis risk
- Instrument may assess kinesiophobia, outcomes in patients with patellofemoral instability
- Intervention helped involuntary discharged patients on hemodialysis regain access to care
- Laparoscopy may offer advantages to laparotomy for some women with ovarian cancer
- Liver stiffness measurements may ‘personalize’ HCC risk, surveillance needs in MASLD
- Nasal spray form of bumetanide may be just as good as oral, IV
- New guidance aims to improve representation in Alzheimer’s research
- Novel farnesoid X receptor agonist safe, reduces liver fat content by up to 22.8% in MASH
- Obesity drugs could help lower alcohol intake
- Optimal serum urate targets may change with stages of gout treatment
- Pediatric asthma ‘potential source of cognitive difficulty’
- Proximal femoral replacement may effectively salvage complex revision THA cases
- Q&A: Expert dives into first-ever national report detailing health impacts of psoriasis
- Rivaroxaban fails to prevent cognitive decline, stroke in younger adults with AF
- Stem cell transplantation does not increase risk for clonal hematopoiesis
- Top in cardiology: Tirzepatide for obesity-related HF; ‘weekend warrior’ exercise pattern
- Ultra-widefield, 7-field imaging show concordance for diabetic retinopathy grading
- VIDEO: ‘Flurry of activity’ in treatment space for EGFR-mutated lung cancer
- VIDEO: AI could be used to ‘integrate everything’ about mental and physical health
- VIDEO: Cataract surgery planning tools streamline lens calculations, minimize errors
- VIDEO: Collective understanding of biomarker testing important for EGFR-mutated lung cancer
- VIDEO: Expert offers advice for residents seeing patients with EGFR-mutated lung cancer
- VIDEO: Future use of antibody-drug conjugates in EGFR-mutated lung cancer
- VIDEO: IDSA president emphasizes critical role pediatric providers play in ID
- VIDEO: Improving immune checkpoint inhibitor use in EGFR-mutated lung cancer
- VIDEO: Monitoring for brain metastases key in patients with recurrent EGFR-mutated lung cancer
- VIDEO: Pros, cons of complement inhibitors debated at AAO meeting